Literature DB >> 15964669

Improved intranasal immunization with live-attenuated measles virus after co-inoculation of the lipopeptide MALP-2.

Anke Lührmann1, Thomas Tschernig, Reinhard Pabst, Stefan Niewiesk.   

Abstract

The macrophage-activating lipopeptide with a molecular weight of 2kDa (MALP-2) activates antigen presenting cells of human, mouse and rat origin in vitro and in vivo. Here, we demonstrate that MALP-2 induces MIP1alpha and beta, MIP-2, Gro, TNFalpha, IL1alpha and IL6 in cells of cotton rats (Sigmodon hispidus) in vitro. Intranasal inoculation into cotton rats leads to migration of neutrophils and other leucocytes into the lung lumen and lung tissue. After intranasal co-inoculation of MALP-2 with live-attenuated measles vaccine virus, higher titers of neutralizing antibodies are induced but the proliferative T cell response did not increase. Immunization leads to protective immunity in the absence, but not in the presence of passively transferred measles virus (MV) specific antibodies.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15964669     DOI: 10.1016/j.vaccine.2005.05.009

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  7 in total

1.  Synthetic lipopeptide MALP-2 inhibits intracellular growth of Mycobacterium bovis BCG in alveolar macrophages-preliminary data.

Authors:  Grit Jörgens; Franz-Christoph Bange; Peter F Mühlradt; Reinhard Pabst; Ulrich A Maus; Thomas Tschernig
Journal:  Inflammation       Date:  2009-08       Impact factor: 4.092

2.  Coincidence of different structures of mucosa-associated lymphoid tissue (MALT) in the respiratory tract of children: no indications for enhanced mucosal immunostimulation in sudden infant death syndrome (SIDS).

Authors:  A S Debertin; T Tschernig; A Schürmann; T Bajanowski; B Brinkmann; R Pabst
Journal:  Clin Exp Immunol       Date:  2006-10       Impact factor: 4.330

3.  TLR2/6 stimulation of the rat lung: effects on lymphocyte subsets, natural killer cells and dendritic cells in different parts of the air-conducting compartments and at different ages.

Authors:  Reinhard Pabst; Deniz Durak; Anna Roos; Anke Lührmann; Thomas Tschernig
Journal:  Immunology       Date:  2008-06-19       Impact factor: 7.397

4.  Effects of the TLR2 agonists MALP-2 and Pam3Cys in isolated mouse lungs.

Authors:  Martina Barrenschee; Dennis Lex; Stefan Uhlig
Journal:  PLoS One       Date:  2010-11-16       Impact factor: 3.240

5.  Beneficial effects of TLR-2/6 ligation in pulmonary bacterial infection and immunization with Pseudomonas aeruginosa.

Authors:  Tanja Kerber-Momot; Damaris Leemhuis; Anke Lührmann; Antje Munder; Burkhard Tümmler; Reinhard Pabst; Thomas Tschernig
Journal:  Inflammation       Date:  2010-02       Impact factor: 4.092

6.  TLR-2 activation induces regulatory T cells and long-term suppression of asthma manifestations in mice.

Authors:  Martijn C Nawijn; Alexandre C Motta; Renée Gras; Soheila Shirinbak; Hadi Maazi; Antoon J M van Oosterhout
Journal:  PLoS One       Date:  2013-02-05       Impact factor: 3.240

7.  Modulation of asthma and allergy by addressing toll-like receptor 2.

Authors:  Barbara Fuchs; Armin Braun
Journal:  J Occup Med Toxicol       Date:  2008-02-27       Impact factor: 2.646

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.